Dimple Modi

837 total citations
34 papers, 604 citations indexed

About

Dimple Modi is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dimple Modi has authored 34 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Hematology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dimple Modi's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Dimple Modi is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Dimple Modi collaborates with scholars based in United States, Spain and Japan. Dimple Modi's co-authors include Joanna E. Burdette, Daniel D. Lantvit, Hugo Y. Hsu, Johannes Wolff, Sharon L. Eddie, Gossett A. Campbell, Beibei Hu, Sarina A. Piha‐Paul, Jason Bugno and David A. Davis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dimple Modi

33 papers receiving 595 citations

Peers

Dimple Modi
Katia Bifulco Italy
Masaki Fukuda Japan
Maureen E. Lane United States
Yanli Sun China
G Pizzorno United States
Steven J. Glassman Canada
Boaz Nachmias Israel
Rosalía I. Cordo Russo Argentina
Ronald J. Whitley United States
Feng‐Pai Chou Taiwan
Katia Bifulco Italy
Dimple Modi
Citations per year, relative to Dimple Modi Dimple Modi (= 1×) peers Katia Bifulco

Countries citing papers authored by Dimple Modi

Since Specialization
Citations

This map shows the geographic impact of Dimple Modi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimple Modi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimple Modi more than expected).

Fields of papers citing papers by Dimple Modi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimple Modi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimple Modi. The network helps show where Dimple Modi may publish in the future.

Co-authorship network of co-authors of Dimple Modi

This figure shows the co-authorship network connecting the top 25 collaborators of Dimple Modi. A scholar is included among the top collaborators of Dimple Modi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimple Modi. Dimple Modi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lakhani, Nehal J., Omid Hamid, Irene Braña, et al.. (2024). A phase 1 study of REGN6569, a GITR mAb, in combination with cemiplimab in patients (pts) with advanced solid tumor malignancies: Initial dose-escalation results.. Journal of Clinical Oncology. 42(16_suppl). 2650–2650. 2 indexed citations
4.
Modi, Dimple, et al.. (2024). Long acting injectables for the treatment of prostate cancer. Journal of Drug Delivery Science and Technology. 100. 105996–105996. 9 indexed citations
5.
Kim, Tae Min, Charles Ricordel, Jhanelle E. Gray, et al.. (2024). 1302P MET×MET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) study. Annals of Oncology. 35. S828–S829. 2 indexed citations
6.
Tahir, Stephen K., Emiliano Calvo, Benedito A. Carneiro, et al.. (2023). Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 141(17). 2114–2126. 9 indexed citations
7.
Modi, Dimple, Sriramakamal Jonnalagadda, Gossett A. Campbell, & Gautam Dalwadi. (2023). Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis. Journal of Pharmaceutical Sciences. 112(9). 2427–2443. 7 indexed citations
8.
LoRusso, Patricia, Mark J. Ratain, Toshihiko Doi, et al.. (2022). Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study. Investigational New Drugs. 40(4). 762–772. 19 indexed citations
9.
10.
Modi, Dimple, et al.. (2020). Accelerate development of topical cream drug product using a common platform base formulation. Pharmaceutical Development and Technology. 25(6). 767–778. 7 indexed citations
11.
Piha‐Paul, Sarina A., Jasgit C. Sachdev, Minal Barve, et al.. (2019). First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors. Clinical Cancer Research. 25(21). 6309–6319. 116 indexed citations
12.
13.
Odenike, Olatoyosi, Johannes Wolff, Gautam Borthakur, et al.. (2019). Results from the first-in-human study of mivebresib (ABBV-075), a pan-inhibitor of bromodomain and extra terminal proteins, in patients with relapsed/refractory acute myeloid leukemia.. Journal of Clinical Oncology. 37(15_suppl). 7030–7030. 9 indexed citations
14.
Russo, Angela, Matthew Dean, Dimple Modi, et al.. (2018). PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene. 37(15). 1976–1990. 56 indexed citations
15.
Hsu, Hugo Y. & Dimple Modi. (2015). Etiologies, Quantitative Hypoesthesia, and Clinical Outcomes of Neurotrophic Keratopathy. Eye & Contact Lens Science & Clinical Practice. 41(5). 314–317. 34 indexed citations
16.
Quartuccio, Suzanne M., Sharon L. Eddie, Daniel D. Lantvit, et al.. (2015). Mutant p53 expression in fallopian tube epithelium drives cell migration. International Journal of Cancer. 137(7). 1528–1538. 39 indexed citations
17.
Modi, Dimple & Sander R. Dubovy. (2013). Non-leaking Cystoid Maculopathy Secondary to Systemic Paclitaxel. Ophthalmic surgery, lasers & imaging retina. 44(2). 183–186. 16 indexed citations
18.
King, Shelby M., Dimple Modi, Sharon L. Eddie, & Joanna E. Burdette. (2013). Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. Journal of Ovarian Research. 6(1). 12–12. 23 indexed citations
19.
Modi, Dimple, et al.. (2009). Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Modi, Dimple, Deepak P. Edward, Lawrence Ulanski, et al.. (2007). MYCOBACTERIUM HAEMOPHILUM. Retina. 27(8). 1148–1151. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Bifulco Breakdown of academic impact, for papers by Masaki Fukuda Breakdown of academic impact, for papers by Maureen E. Lane Breakdown of academic impact, for papers by Yanli Sun Breakdown of academic impact, for papers by G Pizzorno Breakdown of academic impact, for papers by Steven J. Glassman Breakdown of academic impact, for papers by Boaz Nachmias Breakdown of academic impact, for papers by Rosalía I. Cordo Russo Breakdown of academic impact, for papers by Ronald J. Whitley Breakdown of academic impact, for papers by Feng‐Pai Chou
Rankless by CCL
2026